ISX, back in with small parcel other day, will accrue on weakness, moving into a period were model will be validated or ......
Fintech but with a difference, not same model as the lenders APT,EML,Z1P and such.
Much more alingned to a generic banking structure.
Bottom line we have a MC > 200m with no metric support so beware, also company has a history of over promising.
Only reason I draw this stock to forums attention is amount of professional noise in marketplace especially post RC, I sold @ 15 on last 4c and since then nothing but phone calls and a rising SP. Noise reminds me of CYP < 60, difference ISX operating on much shorter leadtime to model validation.
Latest investor presso and anns this morning for the forums perusal.